Translational Neuroscience (Dec 2021)

Bone marrow mesenchymal stem cells overexpressing hepatocyte growth factor ameliorate hypoxic–ischemic brain damage in neonatal rats

  • Zeng Wen,
  • Wang Yu,
  • Xi Yufeng,
  • Wei Guoqing,
  • Ju Rong

DOI
https://doi.org/10.1515/tnsci-2020-0204
Journal volume & issue
Vol. 12, no. 1
pp. 561 – 572

Abstract

Read online

Hypoxic–ischemic brain damage (HIBD) is a major cause of brain injury in neonates. Bone marrow mesenchymal stem cells (BMSCs) show therapeutic potential for HIBD, and genetic modification may enhance their neuroprotective effects. The goal of this study was to investigate the neuroprotective effects of hepatocyte growth factor (HGF)-overexpressing BMSCs (BMSCs-HGF) against HIBD and their underlying mechanisms.

Keywords